SERA PROGNOSTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
SERA PROGNOSTICS, INC. (SERA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 60.90 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 41.83K shares, a 38.37% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 19.07K shares, a 800.42% increase year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 11.89K shares, a 17.76% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 87.33K shares, a 1109.89% increase year-over-year.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 169.22K shares, a 40.56% increase from fiscal 2024.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 120.39K shares, a 92.29% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.56M shares, a 68.58% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 926.02K shares, a 2109.76% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 41.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 60.90K shares 10-Q · filed 2026-08-12 | 72.79K shares derived: sum of 3 quarters · filed 2026-08-12 | 160.12K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 19.07K shares 10-Q · filed 2026-05-06 | 30.96K shares derived: sum of 2 quarters · filed 2026-05-06 | 118.29K shares derived: sum of 3 quarters · filed 2026-05-06 | 186.17K shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 11.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 99.22K shares derived: sum of 2 quarters · filed 2026-03-18 | 167.10K shares derived: sum of 3 quarters · filed 2026-03-18 | 169.22K shares 10-K · filed 2026-03-18 |
| 2025-09-30 | 87.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 155.21K shares derived: sum of 2 quarters · filed 2025-11-13 | 157.32K shares 10-Q · filed 2025-11-13 | 171.78K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 67.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 70.00K shares 10-Q · filed 2025-08-06 | 84.45K shares derived: sum of 3 quarters · filed 2025-08-06 | 91.67K shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 2.12K shares 10-Q · filed 2025-05-07 | 16.58K shares derived: sum of 2 quarters · filed 2025-05-07 | 23.80K shares derived: sum of 3 quarters · filed 2025-05-07 | 78.60K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 14.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 21.68K shares derived: sum of 2 quarters · filed 2025-03-19 | 76.48K shares derived: sum of 3 quarters · filed 2025-03-19 | 120.39K shares 10-K · filed 2025-03-19 |
| 2024-09-30 | 7.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 62.02K shares derived: sum of 2 quarters · filed 2024-11-06 | 105.93K shares 10-Q · filed 2024-11-06 | 261.88K shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 54.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 98.71K shares 10-Q · filed 2024-08-07 | 254.66K shares derived: sum of 3 quarters · filed 2024-08-07 | 423.90K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 43.90K shares 10-Q · filed 2024-05-08 | 199.86K shares derived: sum of 2 quarters · filed 2024-05-08 | 369.09K shares derived: sum of 3 quarters · filed 2024-05-08 | 1.44M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 155.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 325.19K shares derived: sum of 2 quarters · filed 2024-03-20 | 1.40M shares derived: sum of 3 quarters · filed 2024-03-20 | 1.56M shares 10-K · filed 2024-03-20 |
| 2023-09-30 | 169.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 1.24M shares derived: sum of 2 quarters · filed 2023-11-08 | 1.41M shares 10-Q · filed 2023-11-08 | 1.64M shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 1.07M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 1.24M shares 10-Q · filed 2023-08-09 | 1.47M shares derived: sum of 3 quarters · filed 2023-08-09 | 1.75M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 161.37K shares 10-Q · filed 2023-05-10 | 392.49K shares derived: sum of 2 quarters · filed 2023-05-10 | 673.76K shares derived: sum of 3 quarters · filed 2023-05-10 | 1.02M shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 231.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 512.39K shares derived: sum of 2 quarters · filed 2023-03-22 | 860.64K shares derived: sum of 3 quarters · filed 2023-03-22 | 926.02K shares 10-K · filed 2023-03-22 |
| 2022-09-30 | 281.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 629.53K shares derived: sum of 2 quarters · filed 2022-11-09 | 694.91K shares 10-Q · filed 2022-11-09 | 711.75K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 348.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 413.63K shares 10-Q · filed 2022-08-10 | 430.48K shares derived: sum of 3 quarters · filed 2022-08-10 | 455.37K shares derived: sum of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | 65.38K shares 10-Q · filed 2022-05-10 | 82.23K shares derived: sum of 2 quarters · filed 2022-05-10 | 107.11K shares derived: sum of 3 quarters · filed 2022-05-10 | |
| 2021-12-31 | 16.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 41.73K shares derived: sum of 2 quarters · filed 2022-03-29 | 41.91K shares 10-K · filed 2022-03-29 | |
| 2021-09-30 | 24.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 25.06K shares 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | 174.00 shares 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |